Stigmata of high risk gastric ulcers prone to re-bleeding
Active bleeding vessel visible vessel Adherent clot
Reason for biopsies during endocscopy for bleeding uler
Cancer (4% of ulcers) H. Pylori
Modified Johnson classfication for gastric ulcers

Indication for (and type of gastric ulcers) vagotomy and antrectomy (or pyloroplasty)
Type II or III (acid hypersecretion) ulcers resistant to PPI or H.pylori eradication.
vessels needing divided in distal gastrectomy
Right gastroepiploic near GDA
Right gastric
Branches of left gastric
(divide duodenum, stomach 1/2 way between duo and GE junction)
Definition of failure of nonoperatie managmeent for bleeding gastroduodenal ulcers
Three points of suture for bleeding posterior duodenal ulcer plus other surgical principles
Taking care not to injure CBD (may need bile duct probe through cystic duct). Generous Kocher maneuver. Longitudinal pyloroduodenotomy. Biopsies of ulcer bed if possible. Approximation of defect. Close transversely (Heineke).
Jaboulay pyloroplasty
does NOT cross the pylorus

Finney pyloroplasty
Crosses the pylorus

Vagotomy location to ensure Criminal nerve of Grassi is included
4-6 cm proximal from GE junction.
Work up for gastric cancer (essentially same as esophageal cancer)
Surveillance for gastric cancer
same as colon cancer except CT C/A/P annually up to 5 years
PET as indicted
watch for B12 and iron deficiency
Unresectable (aside from metastatic disease) for gastric cancer
Invasion of root of mesentery or positive para-aortic LN
Invasion of arterial structures (excpet for splenic artery)
D1 reseaction
Perigastric LN with greater and lesser omentum
D2 resection
D1 + LN dissection along celiac axis (commong hepatic, splenic, left gastric, and celiac) Do not do splenectomy.
Genetic syndromes pre-disposed to gastric cancer
Hereditary diffuse gastric cancer prophylacitc surgery
CDH1
prophylactic gastrectomy (without D2 LN dissection) between 18-40 with frozen sections of esophageal and duodenal margin to ensure gastric tissue removed.
Screening needed for gastric cancer
STage II gastric cancer
Perioperative therapy for gastric cancer (T2 or above)
OS in FLOT vs ECF was 50 vs 35 months
Perioperative FLOT (5FU, Leucovorin, Oxaliplatin, Docetaxol) if good performance status
Perioperative FOLFOX of moderate performance status
Post operative chemoradiation if recieve less than D2 LN dissection.
Stomach NETs (3 types and treatment)
BMI with higher Nissen failure rates (should consider R n Y)
BMI > 35
Nerve of Laterjet
Anterior division of anterior vagus (innervates the anterior stomach)
Bismuth quadruple therapy (10-14 day treatment)
Bismuth, flagyl, tetracycline, PPI